BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Sponsored: In mRNA Production, You Get Out What You Put In

  Choose your raw materials wisely

  April 10, 2023

   · 

  2 min read
• 

  Business

  In Another Round of Cuts, Biogen Lays Off Unspecified Number of Employees

  The Boston Business Journal reported the layoffs would affect the multiple sclerosis team, but Biogen declined to confirm the details.

  April 10, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Drug Development

  AbbVie, J&J Pull Two Accelerated Approvals for Imbruvica

  AbbVie and Johnson & Johnson will withdraw the accelerated approvals for Imbruvica in mantle cell lymphoma and marginal zone lymphoma, the companies announced Thursday.

  April 10, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• Drug Development

  Nuance Pharma Announces Dosing of First Patient in ENHANCE – China Phase 3 Trial for COPD

  Verona Pharma plc announces its development partner, Nuance Pharma, has dosed the first subject in its ENHANCE - China Phase 3 trial for the maintenance treatment of chronic obstructive pulmonary disease.

  April 10, 2023

   · 

  7 min read
• Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

  Bright Minds Biosciences Inc. today announced that Alex Vasilkevich, Bright Minds’ Scientific Officer, will present at the 20th International Meeting of the International Society for Serotonin Research (ISSR).

  April 10, 2023

   · 

  5 min read
• Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the National Kidney Foundation (NKF) 2023 Spring Clinical Meeting (SCM)

  Two scientific abstracts spanning clinical and health economic outcomes research will be presented at the 2023 NKF SCM, showcasing the breadth of Mallinckrodt’s commitment to HRS patients with rapid reduction in kidney function.

  April 10, 2023

   · 

  9 min read
• Business

  TScan Therapeutics Announces Appointment of Barbara Klencke, M.D., to its Board of Directors

  TScan Therapeutics, Inc. today announced the appointment of Barbara Klencke, M.D., to its Board of Directors, effective April 6, 2023.

  April 10, 2023

   · 

  9 min read
• Pharm Country

  Anavex Life Sciences to Present at the 22nd Annual Needham Virtual Healthcare Conference 2023

  Anavex Life Sciences Corp. today announced that Christopher U Missling, PhD, President & Chief Executive Officer of Anavex will present at the 22nd Annual Needham Virtual Healthcare Conference 2023 on Monday, April 17, 2023, at 8:00 AM ET.

  April 10, 2023

   · 

  3 min read
• Drug Development

  Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single-Ascending Dose and Multiple-Ascending Dose Trial of Adjunctive EVX-101 in Healthy Volunteers Treated With a First-Line Antidepressant

  Evecxia Therapeutics, Inc. today announced favorable safety, tolerability, pharmacokinetic, and pharmacodynamic data from a double-blind, placebo-controlled Phase 1, a two-part single ascending dose (SAD) and multiple ascending dose (MAD) trial of EVX-101 in healthy volunteers treated with escitalopram.

  April 10, 2023

   · 

  5 min read
• Business

  Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)

  Aviceda is partnering with world-renowned scientist Professor Christopher Scott and his teams at the Patrick G. Johnson Centre for Cancer Research at Queen’s University Belfast to spearhead development of the next generation of glyco-immune therapeutics.

  April 10, 2023

   · 

  5 min read